Standout Papers

Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs) 2020 2026 2022 2024283
  1. Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs) (2020)
    Jessica Iegre, Daniel H. O’Donovan et al. Chemical Society Reviews

Immediate Impact

2 from Science/Nature 50 standout
Sub-graph 1 of 22

Citing Papers

ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
2 intermediate papers

Works of Daniel H. O’Donovan being referenced

Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection
2023
Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs)
2020 Standout

Author Peers

Author Last Decade Papers Cites
Daniel H. O’Donovan 436 296 132 27 794
Jenny Wai 422 224 129 18 772
Bayard R. Huck 730 378 175 28 978
Jessica Iegre 511 177 164 19 674
Reik Löser 375 218 184 53 817
John C. Widen 425 305 93 16 828
Gunnar J. Hanson 541 333 55 37 817
Federica Pisaneschi 252 323 121 49 683
Sofia Nascimento dos Santos 302 488 95 36 924
Justin K. Murray 780 313 92 24 923
Song Feng 351 157 129 37 908

All Works

Loading papers...

Rankless by CCL
2026